Evidence map›Paper›PMID 39407704›Full record

ArticleMolecules (Basel, Switzerland)2024

Turn-On Fluorescence Probe for Cancer-Related

Muhammad Saleem, Muhammad Hanif, Samuel Bonne, Muhammad Zeeshan, Salahuddin Khan, Muhammad Rafiq, Tehreem Tahir, Changrui Lu, Rujie Cai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Muhammad SaleemShanghai Key Laboratory of Plant Molecular Sciences, College of Life Sciences, Shanghai Normal University, Shanghai 200234, China.ORCID 0000-0002-6441-5112
Muhammad HanifDepartment of Chemistry, GC University Faisalabad, Sub Campus, Layyah 31200, Pakistan.
Samuel BonneFaculty of Medicine, McGill University, Montreal, QC H3A 0G4, Canada.ORCID 0009-0005-5373-4176
Muhammad ZeeshanDepartment of Chemistry, GC University Faisalabad, Sub Campus, Layyah 31200, Pakistan.
Salahuddin KhanCollege of Engineering, King Saud University, P.O. Box 800, Riyadh 11421, Saudi Arabia.ORCID 0000-0002-6082-3418
Muhammad RafiqDepartment of Physiology and Biochemistry, Cholistan University of Veterinary and Animal Sciences, Bahawalpur 6300, Pakistan.ORCID 0000-0001-9686-6551
Tehreem TahirDepartment of Physiology and Biochemistry, Cholistan University of Veterinary and Animal Sciences, Bahawalpur 6300, Pakistan.ORCID 0000-0002-1382-1946
Changrui LuDepartment of Biosciences, College of Biological Sciences and Medical Engineering, Donghua University, 2999 North Ren Min Road, Shanghai 201620, China.
Rujie CaiShanghai Key Laboratory of Plant Molecular Sciences, College of Life Sciences, Shanghai Normal University, Shanghai 200234, China.

Funding

Shanghai Sailing Program (21YF1433000), China 21YF1433000
6 · The paper itself

Abstract

The design and development of fluorescent materials for detecting cancer-related enzymes are crucial for cancer diagnosis and treatment. Herein, we present a substituted rhodamine derivative for the chromogenic and fluorogenic detection of the cancer-relevant enzyme

Indexed as

Fluorescent Dyesgamma-GlutamyltransferaseNeoplasmsAnimalsHumansMolecular Docking SimulationRhodaminesSpectrometry, FluorescenceFluorescent Dyesgamma-GlutamyltransferaseRhodaminesbioimagingfensorfluorescencemolecular dockingγ-glutamyltranspeptidase

Identifiers

PMID39407704
PMCPMC11477498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.